NCT03470610View on ClinicalTrials.gov

Administration of Vaginal and Rectal Progesterone During FET Cycles

CompletedOBSERVATIONAL
Enrollment

277

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

February 1, 2019

Study Completion Date

September 1, 2019

Conditions
Infertility
Interventions
DRUG

Progesterone

6 mg estradiol and vaginal and rectal progesterone

Trial Locations (1)

7800

Fertility Clinic Regional Hospital Skive, Skive

All Listed Sponsors
lead

Thor Haahr

OTHER

NCT03470610 - Administration of Vaginal and Rectal Progesterone During FET Cycles | Biotech Hunter | Biotech Hunter